Shares of Alcon, Inc. ACL are higher on the session by 0.06%, currently trading at $165.31. The stock has been moving largely higher over the past four months and is currently trading above the 50-day and 200-day moving averages.
Options traders are buying puts on the name today. A short while ago the April 2011 $130.00 put was purchased 2,520 times, on the offer, for $0.15 on open interest of 0 contracts.
Overall put volume is now running at 3.76x the daily average with 98% of all puts traded being purchases on the offer.
Alcon, Inc. is a research and development global medical specialty company focused on eye care. The company develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat primarily diseases and disorders of the eye.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.